Mesa Laboratories [MLAB] vs Coherent [COHR] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Mesa Laboratories Inc. wins in 11 metrics, Coherent Corp. wins in 9 metrics, with 0 ties. Mesa Laboratories Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Mesa Laboratories Inc. | Coherent Corp. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 156.38 | 334.34 | Mesa Laboratories Inc. |
| Price-to-Book Ratio | 3.01 | 7.41 | Mesa Laboratories Inc. |
| Debt-to-Equity Ratio | 91.07 | 39.90 | Coherent Corp. |
| PEG Ratio | -0.50 | 3.75 | Coherent Corp. |
| EV/EBITDA | 16.60 | 54.90 | Mesa Laboratories Inc. |
| Profit Margin (TTM) | 1.51% | 4.66% | Coherent Corp. |
| Operating Margin (TTM) | 12.25% | 11.78% | Mesa Laboratories Inc. |
| EBITDA Margin (TTM) | 12.25% | 11.78% | Mesa Laboratories Inc. |
| Return on Equity | 2.18% | 3.24% | Coherent Corp. |
| Return on Assets (TTM) | 2.47% | 2.90% | Coherent Corp. |
| Free Cash Flow (TTM) | $42.31M | $192.76M | Coherent Corp. |
| Dividend Yield | 0.99% | N/A | N/A |
| 1-Year Return | 8.63% | 397.65% | Coherent Corp. |
| Price-to-Sales Ratio (TTM) | 2.27 | 10.06 | Mesa Laboratories Inc. |
| Enterprise Value | $701.15M | $66.33B | Coherent Corp. |
| EV/Revenue Ratio | 2.83 | 10.54 | Mesa Laboratories Inc. |
| Gross Profit Margin (TTM) | 64.18% | 36.95% | Mesa Laboratories Inc. |
| Revenue per Share (TTM) | $45 | $40 | Mesa Laboratories Inc. |
| Earnings per Share (Diluted) | $0.65 | $1.01 | Coherent Corp. |
| Beta (Stock Volatility) | 0.89 | 1.91 | Mesa Laboratories Inc. |
| Short % of Float | 5.82% | 6.88% | Mesa Laboratories Inc. |
Mesa Laboratories Inc. vs Coherent Corp. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mesa Laboratories Inc. | -1.33% | -4.04% | 7.89% | 31.78% | 33.73% | 31.03% |
| Coherent Corp. | 7.48% | 2.96% | 8.21% | 67.30% | 131.91% | 112.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mesa Laboratories Inc. | 8.63% | -22.18% | -59.46% | -13.74% | 234.96% | 612.70% |
| Coherent Corp. | 397.65% | 601.71% | 470.75% | 1,845.58% | 1,494.33% | 4,107.98% |
Performance & Financial Health Analysis: Mesa Laboratories Inc. vs Coherent Corp.
| Metric | MLAB | COHR |
|---|---|---|
| Market Information | ||
| Market Cap | $535.35M | $63.01B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 89,033 | 5,422,893 |
| 90 Day Avg. Volume | 122,281 | 7,735,194 |
| Last Close | $104.08 | $413.84 |
| 52 Week Range | $55.45 - $113.99 | $77.84 - $440.00 |
| % from 52W High | -8.69% | -5.95% |
| All-Time High | $333.42 (Dec 27, 2021) | $440.00 (Jun 03, 2026) |
| % from All-Time High | -68.78% | -5.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.18% |
| Quarterly Earnings Growth | 0.04% | 0.42% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.05% |
| Operating Margin (TTM) | 0.12% | 0.12% |
| Return on Equity (TTM) | 0.02% | 0.03% |
| Debt to Equity (MRQ) | 91.07 | 39.90 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $33.79 | $45.56 |
| Cash per Share (MRQ) | $5.52 | $4.64 |
| Operating Cash Flow (TTM) | $41.53M | $397.10M |
| Levered Free Cash Flow (TTM) | $36.83M | $130.36M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.99% | N/A |
| Last 12-Month Dividend | $0.80 | $0.00 |
Valuation & Enterprise Metrics Analysis: Mesa Laboratories Inc. vs Coherent Corp.
| Metric | MLAB (Apr 24, 2026) | COHR (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 156.38 | 334.34 |
| Forward P/E | 18.86 | 44.47 |
| PEG Ratio | -0.50 | 3.75 |
| Price to Sales (TTM) | 2.27 | 10.06 |
| Price to Book (MRQ) | 3.01 | 7.41 |
| Market Capitalization | ||
| Market Capitalization | $535.35M | $63.01B |
| Enterprise Value | $701.15M | $66.33B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.83 | 10.54 |
| Enterprise to EBITDA | 16.60 | 54.90 |
| Risk & Other Metrics | ||
| Beta | 0.89 | 1.91 |
| Book Value per Share (MRQ) | $33.79 | $45.56 |
Financial Statements Comparison: Mesa Laboratories Inc. vs Coherent Corp.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MLAB (2025) | COHR (2025) |
|---|---|---|
| Revenue/Sales | 240.98M | 5.81B |
| Cost of Goods Sold | 90.11M | 3.77B |
| COGS % of Revenue | 37.4% | 64.8% |
| Gross Profit | 150.87M | 2.04B |
| Gross Margin | 62.6% | 35.2% |
| Research & Development | 19.52M | 581.92M |
| Operating Income (EBIT) | 16.34M | 534.95M |
| Operating Margin | 6.8% | 9.2% |
| EBITDA | 39.46M | 1.14B |
| EBITDA Margin | 16.4% | 19.6% |
| Pre-Tax Income | 5.96M | 94.18M |
| Pre-Tax Income % of Revenue | 2.5% | 1.6% |
| Income Tax | 7.94M | 64.12M |
| Income Tax % of Revenue | 3.3% | 1.1% |
| Net Income (Profit) | -1.97M | 30.06M |
| Profit Margin | -0.8% | 0.5% |
Balance Sheet & Liquidity Metrics
| Metric | MLAB (2025) | COHR (2025) |
|---|---|---|
| Cash & Equivalents | 27.32M | 909.20M |
| Total Current Assets | 102.69M | 3.93B |
| Total Current Assets % of Revenue | 42.6% | 67.6% |
| Total Current Liabilities | 163.96M | 1.79B |
| Total Current Liabilities % of Revenue | 68.0% | 30.9% |
| Long-Term Debt | 76.90M | 3.66B |
| Long-Term Debt % of Revenue | 31.9% | 63.1% |
| Total Shareholders Equity | 159.83M | 8.48B |
| Retained Earnings | -188.94M | 584.37M |
| Retained Earnings % of Revenue | -78.4% | 10.1% |
| Property, Plant & Equipment | 29.88M | 0 |
Cash Flow Statement Comparison
| Metric | MLAB (2025) | COHR (2025) |
|---|---|---|
| Operating Cash Flow | 39.69M | 601.01M |
| Operating Cash Flow % of Revenue | 16.5% | 10.3% |
| Capital Expenditures | -4.25M | -440.84M |
| Free Cash Flow | 42.31M | 192.76M |
| FCF Margin | 17.6% | 3.3% |
| Debt Repayment | -115.81M | -488.65M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MLAB | COHR |
|---|---|---|
| Shares Short | 220,739 | 10.92M |
| Short Ratio | 1.64 | 1.12 |
| Short % of Float | 5.82% | 6.88% |
| Shares Outstanding | 5.52M | 187.42M |
| Float Shares | 4.94M | 176.61M |
| % Held by Insiders | 5.44% | 0.50% |
| % Held by Institutions | 96.65% | 88.62% |
| % Held by Public | -2.09% | 10.88% |
Dividend Analysis & Yield Comparison: Mesa Laboratories Inc. vs Coherent Corp.
| Metric | MLAB | COHR |
|---|---|---|
| Last 12-Month Dividend | $0.80 | $0.00 |
| Last 12-Month Dividend Yield | 0.99% | N/A |
| 3-Year Avg Annual Dividend | $0.69 | $0.00 |
| 3-Year Avg Dividend Yield | 0.15% | N/A |
| 3-Year Total Dividends | $2.08 | $0.00 |
| Ex-Dividend Date | Feb 27, 2026 | N/A |